Vaping
72
12
19
40
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
18 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.8%
2 terminated out of 72 trials
95.2%
+8.7% vs benchmark
6%
4 trials in Phase 3/4
45%
18 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (72)
E-cigarette Social Media Marketing and Its Perceptions by Youth
Social Media Support Groups for Adolescent Vaping Cessation
Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Behavioral Intervention for Youth to Promote Vaping Cessation
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
Concentration Impact Nicotine Salt
Vape Use Among Younger & Older Smokers
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Early Detection of Vaping-related Vascular Diseases
Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths
TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
Cessation of Smoking Trial in the Emergency Department
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
The Canadian Lung Outcomes in Users of Vaping Devices Study
To Vape or Not to Vape
The Use of tDCS for Vaping Reduction
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
Social Media Vaping Cessation Pilot With Peer Mentors